These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17010151)

  • 1. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet.
    Baglin T
    J Thromb Haemost; 2006 Dec; 4(12):2530-2. PubMed ID: 17010151
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes.
    Cosmi B
    J Thromb Haemost; 2006 Dec; 4(12):2527-9. PubMed ID: 17026645
    [No Abstract]   [Full Text] [Related]  

  • 3. Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosis.
    Malato A; Saccullo G; Iorio A; Ageno W; Siragusa S
    Curr Pharm Des; 2010; 16(31):3483-6. PubMed ID: 20858182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M; Plens K; Wojtowicz W; Undas A
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
    Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
    Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
    J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.
    Park JK; Koo do H; Yoon DH; Lee JN
    Ann Vasc Surg; 2016 Jul; 34():119-34. PubMed ID: 27177705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism.
    Prandoni P
    Adv Exp Med Biol; 2017; 906():89-100. PubMed ID: 27620306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation].
    Calvo Romero JM
    Med Clin (Barc); 2013 Apr; 140(7):310-3. PubMed ID: 22995846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
    Kamphuisen PW
    J Thromb Haemost; 2006 Jun; 4(6):1206-7. PubMed ID: 16706960
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Favaretto E; Palareti G
    Thromb Res; 2008; 122(5):610-7. PubMed ID: 18304616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis.
    Perone N; Bounameaux H; Perrier A
    Am J Med; 2001 Jan; 110(1):33-40. PubMed ID: 11152863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-Dimer testing to predict recurrence risk in venous thromboembolism: looking for a useful threshold: a rebuttal.
    Le Gal G; Bounameaux H
    J Thromb Haemost; 2004 Sep; 2(9):1670-2; author reply 1672-5. PubMed ID: 15333049
    [No Abstract]   [Full Text] [Related]  

  • 19. D-dimer and duration of anticoagulation.
    Pernod G; Sevestre MA; Labarere J
    N Engl J Med; 2007 Jan; 356(4):421; author reply 423. PubMed ID: 17251543
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
    Tullett J; Murray E; Nichols L; Holder R; Lester W; Rose P; Hobbs FD; Fitzmaurice D
    BMC Cardiovasc Disord; 2013 Mar; 13():16. PubMed ID: 23497371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.